Product Description
Details- Third generation cephalosporin active against pseudomonas aeruginosa infections.
- First line treatment for the rare tropical infection melioidosis.
- Effective empirical treatment of patients with serious nosocomial infections, with least chances of nephrotoxicity.
- Better treatment option than ceftriaxone / tobramycin combination in treating nosocomial infections.
Dosage: Infants & Children: 1 month to 12 years I.V. 30-50 mg/kg/dose evey 8 hr (max. dose 6g/day)
Adults:I.M.I.V.500 mg to 2 g every 8-12 hrs